Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 37, 2008 - Issue 1
Submit an article Journal homepage
197
Views
14
CrossRef citations to date
0
Altmetric
Article

The cost‐effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data

G. Kobelt Lund University, Sweden; European Health Economics, FranceCorrespondence[email protected]
,
P. Sobocki European Health Economics, Stockholm, Sweden
,
J. Mulero Clinica Puerta de Hierro, Madrid, Spain
,
J. Gratacos Hospital de Sabadell, Barcelona, Spain
,
E. Collantes‐Estevez Hospital Reina Sofia, Corboba, Spain
&
J. Braun Rheumazentrum Herne, Ruhr‐University, Bochum, Germany
Pages 62-71 | Accepted 02 Aug 2007, Published online: 12 Jul 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Krzysztof Piotr Malinowski & Paweł Kawalec. (2015) The indirect costs of ankylosing spondylitis: a systematic review and meta-analysis. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 285-300.
Read now
Timm D Kirchhoff, Thomas Mittendorf, Reinhold E Schmidt, Alexandra Jablonka & Sonja Merkesdal. (2012) Cost–effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 307-317.
Read now

Articles from other publishers (12)

Annelies Boonen & Casper Webers. 2019. Axial Spondyloarthritis. Axial Spondyloarthritis 259 279 .
Larissa Valor, Silvia Díaz-Cerezo, Ana López-Lacey, Ana M. Martínez-Arroyo, Miguel A. Casado & Luis Carreño. (2015) El valor de las terapias biológicas en el tratamiento de las enfermedades reumáticas crónicas. Una revisión sistemática de su evidencia farmacoeconómica en España. PharmacoEconomics Spanish Research Articles 13:2, pages 69-89.
Crossref
Marieke Krol, Jocé Papenburg, Siok Swan Tan, Werner Brouwer & Leona Hakkaart. (2015) A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. The European Journal of Health Economics 17:4, pages 391-402.
Crossref
Mark Corbett, Marta Soares, Gurleen Jhuti, Stephen Rice, Eldon Spackman, Eleftherios Sideris, Thirimon Moe-Byrne, Dave Fox, Helena Marzo-Ortega, Lesley Kay, Nerys Woolacott & Stephen Palmer. (2016) Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation. Health Technology Assessment 20:9, pages 1-334.
Crossref
Cécile Gaujoux-Viala & Bruno Fautrel. (2012) Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis. PharmacoEconomics 30:12, pages 1145-1156.
Crossref
John D. Reveille, Antonio Ximenes, Michael M. Ward, Atul Deodhar & Daniel Clegg. (2012) Economic Considerations of the Treatment of Ankylosing Spondylitis. The American Journal of the Medical Sciences 343:5, pages 371-374.
Crossref
Myong Joo HongWan-Hee Yoo. (2012) Biologic Agents in Rheumatic Diseases. Korean Journal of Medicine 82:5, pages 549.
Crossref
Joachim Sieper. 2011. Rheumatology. Rheumatology 1157 1177.e3 .
Hilal Maradit Kremers, Sherine E. Gabriel & Michael F. Drummond. 2011. Rheumatology. Rheumatology 23 28.e5 .
A. R. Neilson, J. Sieper & M. Deeg. (2010) Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany. Rheumatology 49:11, pages 2122-2134.
Crossref
Juergen Braun & Xenofon Baraliakos. (2009) Treatment of ankylosing spondylitis and other spondyloarthritides. Current Opinion in Rheumatology 21:4, pages 324-334.
Crossref
Joachim Sieper & Jürgen BraunJoachim Sieper & Jürgen Braun. 2009. Clinician’s Manual on Ankylosing Spondylitis. Clinician’s Manual on Ankylosing Spondylitis 73 73 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.